Although intraoperative transoesphageal echocardiography (TOE) has an established role in the management of some cardiac surgical procedures, there is little data on its impact on coronary artery bypass graft (CABG) cases that are stratified for clinical risk. This is a retrospective review of the surgical impact of intraoperative TOE on 2,343 unselected cardiac cases. The surgical impact of TOE findings were rated E (essential)-resulted in changes to the proposed surgical procedure or V (valuable)-the surgical technique for the planned surgery was altered. The surgical impact that routine TOE had on low-, medium-and high-risk CABG cases was also examined. The surgical impact of TOE for the total study population (E+V) was 4.5%. The impact was greatest in combined CABG + mitral valve procedures (18%). The impact in CABG cases was 3.5% overall, with an estimated impact in low-risk patients of 2.8% (95%CI. 2.7-3.0%) versus 6.7% (95% CI. 5.9-7.7%) in high-risk cases. The commonest E-impact in CABG patients was unscheduled valve surgery (2.6% of high-risk patients). The complication rate attributable to TOE was 0.09%. These findings provide indirect evidence for a potential patient benefit from the routine use of TOE in cardiac surgery.
From its introduction into cardiac surgical practice in the early 1980s, there has been an explosive growth in the use of perioperative transoesophageal echocardiography (TOE). While it has an accepted role in the routine management of procedures such as valve repairs 1,2 , congenital heart surgery 3 and septal myomectomy 4 , there has been controversy over its value in an unselected cardiac surgical population [5] [6] [7] [8] . Intraoperative TOE has been shown to influence the surgical and anaesthetic management of high-risk coronary artery bypass graft (CABG) patients [9] [10] [11] . Although there are other large series on the impact of intraoperative TOE on cardiac surgical practice [10] [11] [12] [13] , there is no data on the impact of TOE on CABG cases stratified for clinical risk.
The purpose of this study was twofold: Firstly, to investigate the impact that routine intraoperative TOE had on a large, unselected cardiac surgical population, and secondly, to categorize the impact that TOE had on CABG cases by clinical risk.
METHODS
For the past five years intraoperative TOE has been performed routinely on patients undergoing cardiac surgery at Liverpool Public and Royal Prince Alfred Hospitals in Sydney. Following ethics committee approval, the intraoperative TOE databases for both hospitals were combined and examined for the period October 1997-December 2000.
The only contraindication to TOE probe insertion was known oesophageal disease.
Anaesthesia, TOE insertion and examination
The anaesthetic technique in all cases comprised an opiate and benzodiazepine premedication, induction with fentanyl (with or without thiopentone) and maintenance with fentanyl and isoflurane. A pulmonary artery catheter was inserted in nearly all cases.
The TOE probe was inserted following induction in all patients who had no contraindications to its use. At Royal Prince Alfred Hospital, two Hewlett-Packard machines (HP Sonos 1000; Hewlett-Packard, Andover MA) with omniplane 5-MHz probes were used while at Liverpool Hospital a Hewlett-Packard (HP Sonos 5500) with a 7-MHz omniplane probe was used. The level of TOE expertise varied among the anaesthetists although all of them had performed a minimum of 150 examinations prior to the study period and all were performing between 100 and 250 examinations during the study period. As two anaesthetists were assigned to each case (one as a perfusionist), a second opinion on the TOE examination was always immediately available.
A written report of the intraoperative examination was filed along with the TOE videotapes. The TOE report format was standardized between the hospitals. The report contained a section describing the impact that the examination had on patient management (modified from Deutsch 14 ). These categories were: E: Essential-Intraoperative TOE findings resulted in changes to the planned surgical procedure. V: Valuable-Intraoperative TOE findings led to modification of the surgical technique employed for the planned procedure. I: Informative-Intraoperative TOE findings did not lead to surgical alterations but were of other value. N: Uninformative-Intraoperative TOE was of no value over standard monitors. F: False Positive-False positive findings resulted from the use of intraoperative TOE.
Analysis of the intraoperative TOE database
The investigators examined all of the completed TOE records for the study period. Those records where no post-CPB comments were reported were not included for analysis. The proposed operation noted on the TOE form (derived from the operation listed) was noted. The medical records were obtained of all those patients where the examining anaesthetist had recorded an E or a V, or where the post cardiopulmonary bypass (CPB) comments indicated that an E or V classification may have been appropriate when no category had been recorded. After examining the medical record and the operation report, only those cases that were (in the unanimous opinion of the investigators) correctly classified as E, V or F were analysed. Cases where there was disagreement between the investigators were graded I.
All cases where new persisting intraoperative systolic wall motion abnormalities (SWMAs) noted were analysed by the investigators. Only those new SWMAs that had resulted in a change to the surgical technique (e.g. rapidly on to CPB/inspection of grafts/regraft/de-airing manoeuvres) were graded as V. Those SWMAs that did not result in a change to surgical technique were graded I, as were those where surgical intervention would likely have occurred for other reasons (e.g. haemodynamic deterioration resulting in return to CPB and/or intraaortic balloon pump insertion).
In order to further examine the surgical impact that routine TOE had on CABG surgery, those patients who were originally scheduled for CABG surgery and who had E or V scores were retrospectively classified as high, medium or low risk. Risk was classified using the scoring system developed by Surgenor et al 15 ( Table 1) . Clinical risk scores were calculated from a random sample of the medical records of the study CABG populations from both hospitals. This was done to estimate the total number of low, medium and high risk CABG cases in the total study population (and hence the incidence of E and V findings in each of these groups).
RESULTS
Intraoperative TOE was performed on 2,823 patients during the study period. A total of 2,343 (83%) of completed records were suitable for analysis. Fourteen per cent of cases had no post-CPB comments recorded and were not included for analysis and in 3% of cases TOE was not performed as either the probe was not available or could not be introduced into the oesophagus. Mean patient age 735 was 63 years (range: 13-90); male:female distribution was 73%:27%. The operations performed are summarized in Figure 1 . The investigators graded significantly fewer TOE studies as category E (42 vs 67, P<0.05, Chi-square) or V (67 vs 132, P<0.001) than did the examining anaesthetists.
For the total study population, intraoperative TOE findings had a surgical impact in 4.5% of cases. The planned operation was changed in 42 patients (1.8%) and changes in the surgical technique occurred in a further 67 patients (2.9%).
Impact of TOE on scheduled valve procedures
In the 526 patients scheduled for valve procedures, the total surgical impact of intraoperative TOE (E+ V) was 8.0% ( Table 2 ). The surgical impact was highest for scheduled mitral valve procedures. In combined CABG and mitral repair/replacement surgery, TOE findings led to cancellation of the mitral procedure in 8/45 cases (18%). Following mitral valve repair, 4/36 patients (11%) underwent valve replacement because of residual mitral regurgitation.
Impact of TOE on scheduled CABG cases
For scheduled CABG cases (n=1785), the total surgical impact of new intraoperative TOE findings was 3.5% (Table 3 ). New intraoperative TOE findings led to changes to the proposed surgery in 1.1% of cases. The most common major change to the proposed surgery was valve replacement or repair, which occurred in 9/1785 patients (0.5%). Seven of these patients were high-risk cases (2.6% (95% CI.2.3-3.0%)). The estimated incidence of unplanned aortic valve replacement (AVR) in high-risk CABG cases was 4/268 (1.5% (95% CI 1.3-1.7%)) and 3/268 (1.1% (95%CI 1.0-1.3%)) for unscheduled mitral valve repair/replacement (MVR). In an additional 2.4% of all scheduled CABG cases, intraoperative TOE findings resulted in changes to the surgical technique employed. New persisting SWMAs was the commonest finding that influenced surgical management and this was associated with regrafting in 17 (1.0%) patients.
The distribution of clinical risk scores within the sample of patients presenting for CABG surgery is presented in Table 4 . The estimated total surgical impact of routine TOE on CABG cases by patient FIGURE 1 clinical risk was 2.8% for low-risk patients, 2.9% for medium-risk cases and 6.7% for high-risk cases.
Complications
There were two major complications in the 2,343 study patients (0.09%). Postoperative haematemesis occurred in one patient who was found to have a small lower oesophageal laceration that did not require any treatment. In the second patient, a proximal aortic dissection was diagnosed due to the misinterpretation of a reverberation artefact. This led to the patient having an unnecessary aortic graft performed, from which he made an uneventful recovery.
DISCUSSION
The intraoperative use of TOE has been a major advance in cardiac anaesthetic practice, providing unique monitoring and diagnostic capabilities. TOE has an accepted role in the intraoperative management of valve repairs 1,2 , congenital heart surgery 3 , and hypertrophic cardiomyopathy 4 . While TOE has also been shown to be useful in the management of high-risk CABG cases [9] [10] [11] , until now there have been no data on its value in CABG cases that were stratified by clinical risk.
The TOE databases were combined from two hospitals because the investigators considered that there were no major institutional differences in terms of TOE practice, anaesthesia or surgical care. The same TOE reporting form was in use and there was considerable overlap of anaesthetic and surgical practice between the hospitals (4 out of 8 anaesthetists and 3 out of 4 surgeons working at Liverpool Hospital also worked at RPAH).
Our major finding was that the total surgical impact of routine TOE in unselected cardiac surgical patients was 4.5%, while the relative impact varied depending on the planned surgical procedure. This overall impact is somewhat lower than that found by other authors but this may be due to the larger number of low-risk CABG cases in our study. In a prospective study of 3245 patients, the surgical impact of new prebypass TOE findings was 14%. However only 8% of these cases were for CABG and TOE was performed only in patients who had valvular pathology suspected preoperatively 11 , which would be likely to increase its surgical impact. The overall surgical impact of TOE in another series of 1891 cardiac cases was 9.6% 12 . The surgical impact in 916 CABG from this series was 10%, although these cases were not stratified by clinical risk.
Routine TOE and valve surgery
Intraoperative TOE had a substantial impact on the surgical management of patients with ischaemic mitral regurgitation. Cancellation of mitral valve surgery occurred in 8/45 (18%) of patients scheduled for combined CABG and mitral procedures because less mitral regurgitation (MR) was found at the time of surgery than had been identified preoperatively. Although anaesthesia itself may reduce the degree of MR 16 , there was no evidence of significant postoperative MR in these patients on review of their medical records. In a study of 286 patients scheduled for CABG and mitral surgery, the discordance between the degree of MR found intraoperatively and at the time of cardiac catheterization led to cancellation of the mitral procedure in 22 cases (8.9%) 2 . The discordance was greatest in those patients who were clinically unstable at the time of cardiac catheterization and in those patients who had received thrombolytic therapy. None of the cases from that study whose mitral surgery was cancelled intraoperatively required subsequent surgery for MR when followed for up to two years later.
There are other possible explanations for our findings on the impact of TOE on mitral cases. The impact of intraoperative TOE on scheduled valve cases (and on other cases) would clearly be increased if there had been inadequate preoperative cardiological assessment. However, it would be very difficult to examine this factor retrospectively, nor has it been addressed in any prospective studies. Finally, the impact of TOE will clearly be affected by the willingness (or otherwise) of the surgeon to change the operative plan based on intraoperative findings.
Routine TOE for CABG surgery
In patients scheduled for CABG surgery, routine intraoperative TOE resulted in changes to the surgery proposed in 1.1% of cases and altered the surgical technique employed in a further 2.4% of cases. In order to categorize the patients' surgical risk, we used a recently described clinical assessment score that predicts the risk of death from heart failure following CABG surgery which was derived from a prospective study of 8,641 cases 15 . We found that the estimated total surgical impact (E+V classifications) of routine TOE was greatest in high-risk CABG cases (6.7% vs 2.8% of low risk). The role of intraoperative TOE for routine CABG cases has been controversial [5] [6] [7] [8] . In the guidelines of the Society of Cardiovascular Anesthesiologists Ad Hoc Task Force 17 , the routine use of TOE for CABG surgery is a Category II indication (possibly beneficial, but appropriate clinical indications are less certain). This classification is based on the lack of direct evidence that TOE detection of intraoperative myocardial ischaemia improves patient outcome. However, patient outcomes may also be potentially improved when unscheduled valve surgery is performed based on intraoperative TOE findings. We found that this occurred in 9/1785 (0.5%) of our CABG cases overall, with an estimated incidence in high-risk cases of 2.6% (1.5% AVR, 1.1% MV surgery). In most of these cases the decision to perform additional valve surgery was made after consultation with a cardiologist.
Our findings on the impact of TOE on high-risk CABG cases are consistent with those of other authors, although direct comparisons cannot be made as the definition of patient surgical risk varied between studies. In a study of 246 high-risk CABG cases 2 , five patients (2%) underwent unscheduled mitral valve repair based on intraoperative TOE findings, while in another study, six of 82 high-risk CABG patients (7.3%) had unplanned aortic, mitral or pulmonic valve procedures 9 . However in a large series of CABG cases (where the patients were not classified by risk), there were only 9/3,660 (0.24%) unscheduled valve procedures 10 .
The potential impact that unscheduled mitral surgery may have on patient outcome is uncertain. Although uncorrected mitral regurgitation following CABG surgery has been shown to be an independent risk factor affecting long-term survival 18 , the relative merits of surgical versus conservative management of ischaemic mitral dysfunction are unclear 19 . Surgical trials are particularly difficult in this group of patients because of the complex nature of ischaemic mitral regurgitation. In addition, combined CABG/mitral procedures may have a high mortality. Factors that are associated with higher operative mortality are mitral regurgitation due to ischaemic rather than structural causes 20 , poor left ventricular function and surgical experience 21 . Successful mitral valve repair for ischaemic mitral regurgitation may lead to slightly improved long-term survival over mitral valve replacement, but survival is worse following repair if there is more than mild residual mitral regurgitation post-bypass 19 .
There is better indirect evidence that unscheduled AVR in CABG patients may improve outcome 22 . In a study of 62 CABG patients with unoperated mildmoderate aortic stenosis, the estimated requirement for subsequent aortic surgery within six years was 24% 23 . Additionally, the excess operative mortality for combined CABG+AVR versus CABG alone in patients younger than 70 years is low (1.3% vs 4.3% >70) 24 , while there is a high operative mortality for late AVR (14-24%) 22 . These findings suggest that for a patient scheduled for CABG surgery, AVR should be considered if a measurable gradient (20) (21) (22) (23) (24) (25) is found across the aortic valve 22 .
These findings on unscheduled valve surgery in high-risk CABG patients provides indirect evidence that intraoperative TOE may lead to improved patient outcomes.
The overall incidence of SWMAs detected intraoperatively could not be determined from our study as there were no standardized criteria for reporting their occurrence. In a study of 351 CABG cases, the incidence of new SWMAs (lasting at least one minute) detected either pre-or post-CPB was 30% and was associated a doubling of the postoperative myocardial infarction rate 25 .
We noted that usually only severe, persisting SWMAs that resulted in surgical or medical intervention were recorded on the intraoperative TOE report. The 3.8% incidence of post-CPB SWMAs recorded therefore probably represents a significant underestimate of their true incidence. Coronary graft revision was performed in 1% of patients. This finding is consistent with a regraft rate of 0.8% based on intraoperative TOE findings in a study of 3,660 CABG cases 10 . The impact that intraoperative TOE had on the decision to regraft was difficult to determine retrospectively. Although in a number of cases it was noted in the surgical record that the decision to regraft was based on TOE findings, in other cases it may have been based on ECG changes, surgical inspection of the grafts or haemodynamic disturbances. However, the recognition of new SWMAs would have possibly influenced the decision as to which vessels were regrafted. Another potential surgical benefit of intraoperative TOE is that it may have provided reassurance that regrafting was not necessary: for example, when SWMAs were caused by intramyocardial air or when myocardial stunning may have been the possible cause of a SWMA that occurred in an ungrafted area that was known to have a normal coronary circulation. 739 ROUTINE TOE: IMPACT ON CARDIAC SURGERY
LIMITATIONS OF THIS STUDY
As this was a retrospective review it was difficult to determine the precise role that intraoperative TOE had on surgical management. For this reason, the investigators included only those cases where the change in surgical plan was clearly based on intraoperative TOE findings and was unlikely to have occurred for other reasons. Intraoperative TOE clearly altered the surgical management in those patients in whom valve surgery was either performed or cancelled based on unexpected intraoperative findings or when other significant new findings were made. It is therefore unlikely that there was a classification bias in these cases. Cases where the impact of TOE was doubtful were excluded from analysis. For example, in patients scheduled for "mitral valve repair/? replacement," although TOE findings might suggest the possibility of valve repair, the final operative decision to repair the valve may have been made regardless (based on surgical inspection of the valve). This allocation bias would therefore have resulted in an underestimation of the impact of TOE in those cases where the operative decision was based on TOE findings. There may have been a classification bias regarding the impact that SWMA detection had on the surgical decision to regraft (see discussion on routine TOE for CABG surgery). These classification problems are the likely cause of the significant disagreement that occurred between the investigators and the examining anaesthetists regarding the surgical impact of TOE.
Fourteen per cent of studies had no post-CPB comments recorded. It is likely that in these patients there was no change from pre-CPB findings. This would have lead to an increase in the proportion of E and V findings in the study population.
Other limitations of this study were the absence of a control group, which meant that no outcome analysis was possible. Previous authors have noted the logistic and ethical difficulties of conducting controlled trials of intraoperative TOE 26 . Very large studies would be required to demonstrate improvements in low frequency major adverse outcomes such as myocardial infarction or death.
Complications
The incidence of minor complications such as sore throat could not be determined from this study. Two serious complications were noted in the 2,343 study patients from which both patients fortunately made uneventful recoveries. These findings are consistent with the low rate of serious complications reported from other studies. In an intraoperative series of 7200 cardiac cases, TOE-related morbidity occurred in 0.2% of cases 27 . Severe odynophagia was the commonest complication (0.1%) while there was no death due to TOE.
CONCLUSIONS
We found that routine intraoperative TOE had a significant impact on cardiac surgical practice, altering either the planned operation or the surgical technique in 4.5% of unselected cardiac cases. The surgical impact of TOE was greatest in cases involving valve surgery and high-risk CABG patients and lowest in low-risk CABG cases. These findings provide indirect evidence for potential patient benefit from the routine use of TOE in cardiac surgery.
